Veriheal

SEPTEMBER 30, 2021

Cancer patients arguably stand to benefit the most from cannabis’ unique properties and benefits, such as anti-nausea, anti-inflammation, reduced pain, inhibited tumor growth, and appetite stimulation. Even still, the “odds of a cancer patient using marijuana in the past year were essentially flat between 2013 and 2018.”

Patients 98

Patients Research and Development Treatment Consumption 98

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 213

Retail Sleep History Medicine 213

Project CBD

MARCH 21, 2023

For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. Whatever the precise nature of the phantom sound, it often comes with a constellation of symptoms related to the disruption such a condition can bring: sleep problems, difficulty concentrating, low mood, etc.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Researchers Analyzed Survey Results from 280 Epilepsy Patients.

Epilepsy 68

Epilepsy Pharmaceutical Patients Sleep 68

SpeedWeed

APRIL 10, 2021

Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. The data revealed a sustained improvement in the participants’ symptoms. The data revealed a sustained improvement in the participants’ symptoms. View original article.

Chronic Pain 52

Chronic Pain Patients Treatment Data 52

Veriheal

APRIL 23, 2024

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol To collect this data, Veriheal surveyed thousands of patients between the ages of 15 and 27 who signed up for our services between March 2023 and April 2024. It can also help with sleep, as many people like to use cannabis right before bed to feel immediate effects.

Chronic Pain 109

Chronic Pain Data Edibles Sleep 109

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

United Patients Group

MAY 17, 2023

Cannabinoids can promote sleep by activating receptors in the brain called endocannabinoid receptors CB1R and CB2R that regulate sleep cycles, pain perception, immune responses and moods such as depression. They can also promote sleep by activating receptors in the brain that regulate circadian rhythm (the biological clock).

Sleep 78

Sleep Cannabinoids Patients CBD 78

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

LifeCannMD

JANUARY 2, 2024

Here’s a breakdown of how cannabis might help those with Florida qualifying conditions : Florida Cancer Patients : Patients say that it benefits them in several ways: by quelling nausea, suppressing vomiting resulting from chemotherapy, increasing appetite, alleviating pain, and soothing anxiety.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

Veriheal

MAY 18, 2023

annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. The list is designed to help patients determine whether or not they are a good candidate for (and would benefit from) a medical marijuana card. Chronic pain —a condition that affects 50.2

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. Less well-known symptoms include sleep disorders , cognitive changes, pain, anxiety, depression , and hallucinations. More Than 1,000 PD Patients Surveyed.

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. As the disease progresses, individuals may suffer from loss of memory and dementia.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Veriheal

NOVEMBER 21, 2023

Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments. The buddie can be paired with a mobile app that tracks consumption, correlating it with health data from devices like WHOOP, Apple Watch, or Fitbit.

Research and Development 107

Research and Development Consumption Education Data 107

Medical Marijuana 411

MAY 10, 2022

A Cornell University research program, reviewing Medicaid patient data over the past decade in 10 states and Washington DC where recreational marijuana has been legalized, has found that drug prescriptions for anxiety, sleep, pain and seizures have fallen as a result of cannabis legalization, going beyond the findings of similar studies about the impact (..)

Medicine 59

Medicine Legalization Sleep Data 59

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

TheAnswerPage

AUGUST 3, 2021

Does THC have a dose-dependent effect on sleep? Yes – Human experimental data suggests “THC has a dose-dependent effect on sleep—low doses appear to decrease sleep onset latency and increase slow-wave sleep and total sleep time, while high doses appear to cause sleep disturbances.”

Sleep 59

Sleep Data THC Cannabinoids 59

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

The Joint Blog

DECEMBER 12, 2019

For the study researchers “included data from people in 2 prospective cohorts. The most commonly reported therapeutic reasons for cannabis use were pain (36%), sleep (35%), stress (31%), and nausea (30%).” However, there is a lack of research using individual-level data to explore this question. Methods and findings.

Chronic Pain 49

Chronic Pain Patients Data Sleep 49

Cannabis Law Report

JULY 23, 2021

According to a New Frontier Data Report, the overall legal cannabis industry in America is valued at roughly $13.2 We will be expanding production in sync with how the patient population grows, and we will continue to offer the broadest product selection for our patients and continue to innovate as well,” said Ruark.

Tincture 105

Tincture Patients Sleep Retail 105

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Researchers examined studies that used both natural and synthetic THC and CBD.

Cannabinoids 26

Cannabinoids Patients Clinical Trials Research and Development 26

Veriheal

AUGUST 15, 2022

People who suffer from fatigue may struggle with physical exertion, weight fluctuation, depression, emotional imbalance, and sleeping disturbances. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Promising News for Endless Patients.

Treatment 98

Treatment Research and Development Sativa Cannabinoids 98

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. I didn’t realize how tough it was until it stopped.”.

Sleep 52

Sleep Access Patients Treatment 52

The Joint Blog

JANUARY 21, 2020

Marijuana use is associated with subjective benefits in patients with Tourette Syndrome (TS), according to a new study published in the journal Cannabis and Cannabinoid Research. All these patients were asked to complete an online survey (second study part) to receive more detailed data about treatment with CBM.

Patients 29

Patients Marijuana Data Treatment 29

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Project CBD

JANUARY 24, 2019

Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Cannabis and ADHD.

Research and Development 252

Research and Development Chronic Pain Cannabinoids Treatment 252

Cannabis Law Report

DECEMBER 27, 2019

A Windsor, Ontario-based company Audacia Bioscience is especially focussed on three patented technologies that deliver consumer and patient insights to the industry to close the knowledge gaps in the supply chain. Cognizance VCT enables the generation of cost-effective quality data with ethical consent, on par with academic studies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

FloridaMarijuana.net

SEPTEMBER 24, 2018

This efficacy translates to better medicine and better treatments for patients. Myrcene has potent anti-inflammatory, analgesic, and anxiolytic properties, and has benefit in muscle relaxation, and prominent sedation/hypnotic, helpful in sleep. This means that as a team these compounds make cannabis stronger and more efficient.

Terpenes 162

Terpenes Oil Strains Research and Development 162

TheAnswerPage

AUGUST 19, 2022

In a randomized double-blinded placebo-controlled trial, 80 patients undergoing a total knee arthroscopy (TKA) applied topical CBD (n = 19), essential oil (n = 21), CBD and essential oil (n = 21), or placebo (n = 19) 3x/day around the knee for 2 weeks postoperatively. ” Haffar, Khan, Abdelaal et al.

Topical 52

Topical Sleep Oil Collective 52

Cannabis Law Report

AUGUST 24, 2022

The data suggests we have seen a transition from illicit to legal use of medical cannabis, ” said lead researcher Professor Nicholas Lintzeris , from the Faculty of Medicine and Health at the University of Sydney. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

The Cannigma

MARCH 2, 2021

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. Veterans collectively discussed how the use of medical marijuana reduced PTSD symptoms, feelings of anxiety, and helped them sleep better.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

CannaMD

JULY 23, 2020

In the novel study conducted by researchers at the University of New Mexico, nearly 2,000 people self-administered cannabis over a three-year period and reported their marijuana use via the Releaf App that was specifically designed for the study’s data collection needs.

Data 90

Data Chronic Pain Sleep Patients 90

Cannabis Law Report

OCTOBER 18, 2021

This is an exciting opportunity for Canntab, as we believe 36Eight’s unique and valuable complementary platform will support our ability to provide effective solutions for patients while reinforcing the confidence of patients in their relationship with their clinical pharmacist,” said Larry Latowsky , CEO of Canntab.

Data 52

Data Research and Development Patients Cannabinoids 52

Cannabis Law Report

FEBRUARY 2, 2022

As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. We cannot, in good conscience as a society, allow outdated cannabis testing to impose such dangerous and unfair consequences onto medical patients,” founder Lex Beresnev said.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52